Oramed Pharmaceuticals Inc. ( ORMP) - Key Metrics
ORMP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
| 2024Q4 | ? | ? | ? | ? |
ORMP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
| 2024Q4 | ? | ? |
ORMP
Price: $3.77
52 week price:
Dividend Yield: 6.85%
Earnings Per Share: 1.50 USD
P/E Ratio: 2.26
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.6 million
Ebitda: -2.5 millionMarket Capitalization: 149.4 million
Years Paying Dividends: 1